KensaGroup is an Ithaca, New York–based private equity and venture development firm founded in 2000 that commercializes high-potential intellectual property from academic and corporate research into commercially oriented technology businesses. The firm employs a proprietary Academic-to-Industry (A2I™) evaluation and development process to assess, structure, and launch startup ventures around underlying scientific discoveries and platform technologies. KensaGroup’s portfolio spans diverse areas including biotechnology, chemistry, materials, energy, medical devices, and other innovation-led sectors, and the firm works with academic, corporate, and government partners on technology positioning and commercialization strategies. It typically helps bridge scientific research, business formation, and market entry by providing strategic oversight and early-stage support to ventures it helps establish. KensaGroup’s leadership combines scientific, financial, and operational expertise to guide commercialization efforts from concept through early development.